IAL SYSTEM Line

Ial System

HMW hyaluronic acid, 1.8%

Ial System ACP

Auto-cross-linked hyaluronic acid, 2.0%

Ial System DUO

Cross-linked hyaluronic acid + ACP, 2.5%

Fidia
Farmaceutici S.p.A.
Website

Find out our Corporate Website:

Go to the website

Fidia’s other websites

Direct link to:

Key Business Areas

Drawing on the strengths of the parent company, Fidia Pharma Middle East product portfolio focalizes primarily on therapeutic areas such as joint healthcare and tissue repair.

Fidia Pharma Middle East is focused on providing consumers with innovative products that offer quality, safety and performance and exploring innovative channel strategies to access customers and consumers, such as healthcare e-commerce.